Surgical treatment of renal cell carcinoma with extension into the vena cava
| Autor: | B.A. Reitz, Fray F. Marshall, Gary D. Steinberg |
|---|---|
| Rok vydání: | 1991 |
| Předmět: |
Nephrology
medicine.medical_specialty Chemotherapy Kidney Resuscitation business.industry Urology medicine.medical_treatment medicine.disease Surgery law.invention Radiation therapy medicine.anatomical_structure Renal cell carcinoma law Internal medicine medicine Adjuvant therapy Cardiopulmonary bypass business |
| Zdroj: | World Journal of Urology. 9 |
| ISSN: | 1433-8726 0724-4983 |
| DOI: | 10.1007/bf00182836 |
| Popis: | Four to ten percent of patients with renal cell carcinoma have extension of tumor thrombus into the vena cava. These cancers remain resistant to chemotherapy or radiotherapy. Aggressive surgical therapy for these patients, with no apparent evidence of metastatic disease using hypothermia, temporary cardiac arrest and exsanguination with cardiopulmonary bypass, has been demonstrated to be feasible with acceptable morbidity. Unfortunately, many of these patients also have locally advanced disease and approximately 30% have positive lymph nodes at the times of exploration. Survival for these patients is generally unfavorable and is related to the degree of regional tumor spread. However, many who undergo surgical extirpation can return to active lives, if only for 1–2 years. There is at present no effective chemotherapy for advanced renal cell carcinoma, but experimental protocols using combinations of immunotherapy and chemotherapy with encouraging results are currently underway. In the future, these patients may greatly benefit from a combined aggressive surgical approach with reduced morbidity and adjuvant therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink